Global Lipid Nanoparticles (LNPs) CDMO Service Supply, Demand and Key Producers, 2023-2029
The global Lipid Nanoparticles (LNPs) CDMO Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Lipid Nanoparticles (LNPs) CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lipid Nanoparticles (LNPs) CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lipid Nanoparticles (LNPs) CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lipid Nanoparticles (LNPs) CDMO Service total market, 2018-2029, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Lipid Nanoparticles (LNPs) CDMO Service total market, key domestic companies and share, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service revenue by player and market share 2018-2023, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Lipid Nanoparticles (LNPs) CDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Lonza, Rentschler Biopharma, Samsung Biologics, Hanmi Pharmaceutical, Catalent Biologics, FUJIFILM Pharmaceuticals, CordenPharma and ST Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Lipid Nanoparticles (LNPs) CDMO Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Lipid Nanoparticles (LNPs) CDMO Service Market, By Region:
1. How big is the global Lipid Nanoparticles (LNPs) CDMO Service market?
2. What is the demand of the global Lipid Nanoparticles (LNPs) CDMO Service market?
3. What is the year over year growth of the global Lipid Nanoparticles (LNPs) CDMO Service market?
4. What is the total value of the global Lipid Nanoparticles (LNPs) CDMO Service market?
5. Who are the major players in the global Lipid Nanoparticles (LNPs) CDMO Service market?
This report studies the global Lipid Nanoparticles (LNPs) CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lipid Nanoparticles (LNPs) CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lipid Nanoparticles (LNPs) CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lipid Nanoparticles (LNPs) CDMO Service total market, 2018-2029, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Lipid Nanoparticles (LNPs) CDMO Service total market, key domestic companies and share, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service revenue by player and market share 2018-2023, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Lipid Nanoparticles (LNPs) CDMO Service total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Lipid Nanoparticles (LNPs) CDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Lonza, Rentschler Biopharma, Samsung Biologics, Hanmi Pharmaceutical, Catalent Biologics, FUJIFILM Pharmaceuticals, CordenPharma and ST Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Lipid Nanoparticles (LNPs) CDMO Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Lipid Nanoparticles (LNPs) CDMO Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- mRNA-LNP CDMO
- siRNA-LNP CDMO
- pDNA-LNP CDMO
- Others
- Vaccines and Drugs
- Diagnostics and Medical Imaging
- Nanotherapeutics
- Others
- Evonik
- Lonza
- Rentschler Biopharma
- Samsung Biologics
- Hanmi Pharmaceutical
- Catalent Biologics
- FUJIFILM Pharmaceuticals
- CordenPharma
- ST Pharm
- eTheRNA
- Esco Aster
- Recipharm
- Yuantai Biological Technology
- GenScript Biotechnology
- WuXi Biologics
1. How big is the global Lipid Nanoparticles (LNPs) CDMO Service market?
2. What is the demand of the global Lipid Nanoparticles (LNPs) CDMO Service market?
3. What is the year over year growth of the global Lipid Nanoparticles (LNPs) CDMO Service market?
4. What is the total value of the global Lipid Nanoparticles (LNPs) CDMO Service market?
5. Who are the major players in the global Lipid Nanoparticles (LNPs) CDMO Service market?
1 SUPPLY SUMMARY
1.1 Lipid Nanoparticles (LNPs) CDMO Service Introduction
1.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Lipid Nanoparticles (LNPs) CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.3 China Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.4 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.5 Japan Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.6 South Korea Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.7 ASEAN Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.8 India Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Lipid Nanoparticles (LNPs) CDMO Service Major Market Trends
2 DEMAND SUMMARY
2.1 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.2 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region
2.2.1 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region (2018-2023)
2.2.2 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.4 China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.5 Europe Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.6 Japan Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.7 South Korea Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.8 ASEAN Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.9 India Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
3 WORLD LIPID NANOPARTICLES (LNPS) CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lipid Nanoparticles (LNPs) CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lipid Nanoparticles (LNPs) CDMO Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Lipid Nanoparticles (LNPs) CDMO Service in 2022
3.3 Lipid Nanoparticles (LNPs) CDMO Service Company Evaluation Quadrant
3.4 Lipid Nanoparticles (LNPs) CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Lipid Nanoparticles (LNPs) CDMO Service Market: Region Footprint
3.4.2 Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Type Footprint
3.4.3 Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies and Market Share, 2018-2023
4.3.1 United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
4.4 China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue and Market Share, 2018-2023
4.4.1 China Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
4.5 Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 mRNA-LNP CDMO
5.2.2 siRNA-LNP CDMO
5.2.3 pDNA-LNP CDMO
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2018-2023)
5.3.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2024-2029)
5.3.3 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Vaccines and Drugs
6.2.2 Diagnostics and Medical Imaging
6.2.3 Nanotherapeutics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2023)
6.3.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2024-2029)
6.3.3 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Evonik
7.1.1 Evonik Details
7.1.2 Evonik Major Business
7.1.3 Evonik Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.1.4 Evonik Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Evonik Recent Developments/Updates
7.1.6 Evonik Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.2.4 Lonza Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Rentschler Biopharma
7.3.1 Rentschler Biopharma Details
7.3.2 Rentschler Biopharma Major Business
7.3.3 Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.3.4 Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Rentschler Biopharma Recent Developments/Updates
7.3.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.4.4 Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Hanmi Pharmaceutical
7.5.1 Hanmi Pharmaceutical Details
7.5.2 Hanmi Pharmaceutical Major Business
7.5.3 Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.5.4 Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hanmi Pharmaceutical Recent Developments/Updates
7.5.6 Hanmi Pharmaceutical Competitive Strengths & Weaknesses
7.6 Catalent Biologics
7.6.1 Catalent Biologics Details
7.6.2 Catalent Biologics Major Business
7.6.3 Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.6.4 Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Catalent Biologics Recent Developments/Updates
7.6.6 Catalent Biologics Competitive Strengths & Weaknesses
7.7 FUJIFILM Pharmaceuticals
7.7.1 FUJIFILM Pharmaceuticals Details
7.7.2 FUJIFILM Pharmaceuticals Major Business
7.7.3 FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.7.4 FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Pharmaceuticals Recent Developments/Updates
7.7.6 FUJIFILM Pharmaceuticals Competitive Strengths & Weaknesses
7.8 CordenPharma
7.8.1 CordenPharma Details
7.8.2 CordenPharma Major Business
7.8.3 CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.8.4 CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 CordenPharma Recent Developments/Updates
7.8.6 CordenPharma Competitive Strengths & Weaknesses
7.9 ST Pharm
7.9.1 ST Pharm Details
7.9.2 ST Pharm Major Business
7.9.3 ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.9.4 ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ST Pharm Recent Developments/Updates
7.9.6 ST Pharm Competitive Strengths & Weaknesses
7.10 eTheRNA
7.10.1 eTheRNA Details
7.10.2 eTheRNA Major Business
7.10.3 eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.10.4 eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 eTheRNA Recent Developments/Updates
7.10.6 eTheRNA Competitive Strengths & Weaknesses
7.11 Esco Aster
7.11.1 Esco Aster Details
7.11.2 Esco Aster Major Business
7.11.3 Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.11.4 Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Esco Aster Recent Developments/Updates
7.11.6 Esco Aster Competitive Strengths & Weaknesses
7.12 Recipharm
7.12.1 Recipharm Details
7.12.2 Recipharm Major Business
7.12.3 Recipharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.12.4 Recipharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Recipharm Recent Developments/Updates
7.12.6 Recipharm Competitive Strengths & Weaknesses
7.13 Yuantai Biological Technology
7.13.1 Yuantai Biological Technology Details
7.13.2 Yuantai Biological Technology Major Business
7.13.3 Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.13.4 Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Yuantai Biological Technology Recent Developments/Updates
7.13.6 Yuantai Biological Technology Competitive Strengths & Weaknesses
7.14 GenScript Biotechnology
7.14.1 GenScript Biotechnology Details
7.14.2 GenScript Biotechnology Major Business
7.14.3 GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.14.4 GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GenScript Biotechnology Recent Developments/Updates
7.14.6 GenScript Biotechnology Competitive Strengths & Weaknesses
7.15 WuXi Biologics
7.15.1 WuXi Biologics Details
7.15.2 WuXi Biologics Major Business
7.15.3 WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.15.4 WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 WuXi Biologics Recent Developments/Updates
7.15.6 WuXi Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Lipid Nanoparticles (LNPs) CDMO Service Industry Chain
8.2 Lipid Nanoparticles (LNPs) CDMO Service Upstream Analysis
8.3 Lipid Nanoparticles (LNPs) CDMO Service Midstream Analysis
8.4 Lipid Nanoparticles (LNPs) CDMO Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Lipid Nanoparticles (LNPs) CDMO Service Introduction
1.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Lipid Nanoparticles (LNPs) CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.3 China Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.4 Europe Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.5 Japan Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.6 South Korea Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.7 ASEAN Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.3.8 India Lipid Nanoparticles (LNPs) CDMO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Lipid Nanoparticles (LNPs) CDMO Service Major Market Trends
2 DEMAND SUMMARY
2.1 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.2 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region
2.2.1 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region (2018-2023)
2.2.2 World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.4 China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.5 Europe Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.6 Japan Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.7 South Korea Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.8 ASEAN Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
2.9 India Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029)
3 WORLD LIPID NANOPARTICLES (LNPS) CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lipid Nanoparticles (LNPs) CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lipid Nanoparticles (LNPs) CDMO Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Lipid Nanoparticles (LNPs) CDMO Service in 2022
3.3 Lipid Nanoparticles (LNPs) CDMO Service Company Evaluation Quadrant
3.4 Lipid Nanoparticles (LNPs) CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Lipid Nanoparticles (LNPs) CDMO Service Market: Region Footprint
3.4.2 Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Type Footprint
3.4.3 Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies and Market Share, 2018-2023
4.3.1 United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
4.4 China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue and Market Share, 2018-2023
4.4.1 China Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
4.5 Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 mRNA-LNP CDMO
5.2.2 siRNA-LNP CDMO
5.2.3 pDNA-LNP CDMO
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2018-2023)
5.3.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2024-2029)
5.3.3 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Vaccines and Drugs
6.2.2 Diagnostics and Medical Imaging
6.2.3 Nanotherapeutics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2023)
6.3.2 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2024-2029)
6.3.3 World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Evonik
7.1.1 Evonik Details
7.1.2 Evonik Major Business
7.1.3 Evonik Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.1.4 Evonik Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Evonik Recent Developments/Updates
7.1.6 Evonik Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.2.4 Lonza Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Rentschler Biopharma
7.3.1 Rentschler Biopharma Details
7.3.2 Rentschler Biopharma Major Business
7.3.3 Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.3.4 Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Rentschler Biopharma Recent Developments/Updates
7.3.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.4.4 Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Hanmi Pharmaceutical
7.5.1 Hanmi Pharmaceutical Details
7.5.2 Hanmi Pharmaceutical Major Business
7.5.3 Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.5.4 Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hanmi Pharmaceutical Recent Developments/Updates
7.5.6 Hanmi Pharmaceutical Competitive Strengths & Weaknesses
7.6 Catalent Biologics
7.6.1 Catalent Biologics Details
7.6.2 Catalent Biologics Major Business
7.6.3 Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.6.4 Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Catalent Biologics Recent Developments/Updates
7.6.6 Catalent Biologics Competitive Strengths & Weaknesses
7.7 FUJIFILM Pharmaceuticals
7.7.1 FUJIFILM Pharmaceuticals Details
7.7.2 FUJIFILM Pharmaceuticals Major Business
7.7.3 FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.7.4 FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 FUJIFILM Pharmaceuticals Recent Developments/Updates
7.7.6 FUJIFILM Pharmaceuticals Competitive Strengths & Weaknesses
7.8 CordenPharma
7.8.1 CordenPharma Details
7.8.2 CordenPharma Major Business
7.8.3 CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.8.4 CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 CordenPharma Recent Developments/Updates
7.8.6 CordenPharma Competitive Strengths & Weaknesses
7.9 ST Pharm
7.9.1 ST Pharm Details
7.9.2 ST Pharm Major Business
7.9.3 ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.9.4 ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ST Pharm Recent Developments/Updates
7.9.6 ST Pharm Competitive Strengths & Weaknesses
7.10 eTheRNA
7.10.1 eTheRNA Details
7.10.2 eTheRNA Major Business
7.10.3 eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.10.4 eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 eTheRNA Recent Developments/Updates
7.10.6 eTheRNA Competitive Strengths & Weaknesses
7.11 Esco Aster
7.11.1 Esco Aster Details
7.11.2 Esco Aster Major Business
7.11.3 Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.11.4 Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Esco Aster Recent Developments/Updates
7.11.6 Esco Aster Competitive Strengths & Weaknesses
7.12 Recipharm
7.12.1 Recipharm Details
7.12.2 Recipharm Major Business
7.12.3 Recipharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.12.4 Recipharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Recipharm Recent Developments/Updates
7.12.6 Recipharm Competitive Strengths & Weaknesses
7.13 Yuantai Biological Technology
7.13.1 Yuantai Biological Technology Details
7.13.2 Yuantai Biological Technology Major Business
7.13.3 Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.13.4 Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Yuantai Biological Technology Recent Developments/Updates
7.13.6 Yuantai Biological Technology Competitive Strengths & Weaknesses
7.14 GenScript Biotechnology
7.14.1 GenScript Biotechnology Details
7.14.2 GenScript Biotechnology Major Business
7.14.3 GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.14.4 GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GenScript Biotechnology Recent Developments/Updates
7.14.6 GenScript Biotechnology Competitive Strengths & Weaknesses
7.15 WuXi Biologics
7.15.1 WuXi Biologics Details
7.15.2 WuXi Biologics Major Business
7.15.3 WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
7.15.4 WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 WuXi Biologics Recent Developments/Updates
7.15.6 WuXi Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Lipid Nanoparticles (LNPs) CDMO Service Industry Chain
8.2 Lipid Nanoparticles (LNPs) CDMO Service Upstream Analysis
8.3 Lipid Nanoparticles (LNPs) CDMO Service Midstream Analysis
8.4 Lipid Nanoparticles (LNPs) CDMO Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Lipid Nanoparticles (LNPs) CDMO Service Players in 2022
Table 12. World Lipid Nanoparticles (LNPs) CDMO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Lipid Nanoparticles (LNPs) CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Lipid Nanoparticles (LNPs) CDMO Service Player
Table 15. Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Type Footprint
Table 16. Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Application Footprint
Table 17. Lipid Nanoparticles (LNPs) CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Lipid Nanoparticles (LNPs) CDMO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 23. China Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 29. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Evonik Basic Information, Area Served and Competitors
Table 36. Evonik Major Business
Table 37. Evonik Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 38. Evonik Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Evonik Recent Developments/Updates
Table 40. Evonik Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 44. Lonza Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 48. Rentschler Biopharma Major Business
Table 49. Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 50. Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Rentschler Biopharma Recent Developments/Updates
Table 52. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 56. Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Hanmi Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Hanmi Pharmaceutical Major Business
Table 61. Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 62. Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hanmi Pharmaceutical Recent Developments/Updates
Table 64. Hanmi Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Catalent Biologics Basic Information, Area Served and Competitors
Table 66. Catalent Biologics Major Business
Table 67. Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 68. Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Catalent Biologics Recent Developments/Updates
Table 70. Catalent Biologics Competitive Strengths & Weaknesses
Table 71. FUJIFILM Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. FUJIFILM Pharmaceuticals Major Business
Table 73. FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 74. FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. FUJIFILM Pharmaceuticals Recent Developments/Updates
Table 76. FUJIFILM Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. CordenPharma Basic Information, Area Served and Competitors
Table 78. CordenPharma Major Business
Table 79. CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 80. CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. CordenPharma Recent Developments/Updates
Table 82. CordenPharma Competitive Strengths & Weaknesses
Table 83. ST Pharm Basic Information, Area Served and Competitors
Table 84. ST Pharm Major Business
Table 85. ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 86. ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ST Pharm Recent Developments/Updates
Table 88. ST Pharm Competitive Strengths & Weaknesses
Table 89. eTheRNA Basic Information, Area Served and Competitors
Table 90. eTheRNA Major Business
Table 91. eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 92. eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. eTheRNA Recent Developments/Updates
Table 94. eTheRNA Competitive Strengths & Weaknesses
Table 95. Esco Aster Basic Information, Area Served and Competitors
Table 96. Esco Aster Major Business
Table 97. Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 98. Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Esco Aster Recent Developments/Updates
Table 100. Esco Aster Competitive Strengths & Weaknesses
Table 101. Recipharm Basic Information, Area Served and Competitors
Table 102. Recipharm Major Business
Table 103. Recipharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 104. Recipharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Recipharm Recent Developments/Updates
Table 106. Recipharm Competitive Strengths & Weaknesses
Table 107. Yuantai Biological Technology Basic Information, Area Served and Competitors
Table 108. Yuantai Biological Technology Major Business
Table 109. Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 110. Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Yuantai Biological Technology Recent Developments/Updates
Table 112. Yuantai Biological Technology Competitive Strengths & Weaknesses
Table 113. GenScript Biotechnology Basic Information, Area Served and Competitors
Table 114. GenScript Biotechnology Major Business
Table 115. GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 116. GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GenScript Biotechnology Recent Developments/Updates
Table 118. WuXi Biologics Basic Information, Area Served and Competitors
Table 119. WuXi Biologics Major Business
Table 120. WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 121. WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service Upstream (Raw Materials)
Table 123. Lipid Nanoparticles (LNPs) CDMO Service Typical Customers
LIST OF FIGURE
Figure 1. Lipid Nanoparticles (LNPs) CDMO Service Picture
Figure 2. World Lipid Nanoparticles (LNPs) CDMO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Lipid Nanoparticles (LNPs) CDMO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 13. Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Lipid Nanoparticles (LNPs) CDMO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lipid Nanoparticles (LNPs) CDMO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lipid Nanoparticles (LNPs) CDMO Service Markets in 2022
Figure 27. United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type in 2022
Figure 31. mRNA-LNP CDMO
Figure 32. siRNA-LNP CDMO
Figure 33. pDNA-LNP CDMO
Figure 34. Others
Figure 35. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type (2018-2029)
Figure 36. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Application in 2022
Figure 38. Vaccines and Drugs
Figure 39. Diagnostics and Medical Imaging
Figure 40. Nanotherapeutics
Figure 41. Others
Figure 42. Lipid Nanoparticles (LNPs) CDMO Service Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Lipid Nanoparticles (LNPs) CDMO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Lipid Nanoparticles (LNPs) CDMO Service Players in 2022
Table 12. World Lipid Nanoparticles (LNPs) CDMO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Lipid Nanoparticles (LNPs) CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Lipid Nanoparticles (LNPs) CDMO Service Player
Table 15. Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Type Footprint
Table 16. Lipid Nanoparticles (LNPs) CDMO Service Market: Company Product Application Footprint
Table 17. Lipid Nanoparticles (LNPs) CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Lipid Nanoparticles (LNPs) CDMO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 23. China Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Lipid Nanoparticles (LNPs) CDMO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share (2018-2023)
Table 29. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Evonik Basic Information, Area Served and Competitors
Table 36. Evonik Major Business
Table 37. Evonik Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 38. Evonik Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Evonik Recent Developments/Updates
Table 40. Evonik Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 44. Lonza Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 48. Rentschler Biopharma Major Business
Table 49. Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 50. Rentschler Biopharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Rentschler Biopharma Recent Developments/Updates
Table 52. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 56. Samsung Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Hanmi Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Hanmi Pharmaceutical Major Business
Table 61. Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 62. Hanmi Pharmaceutical Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hanmi Pharmaceutical Recent Developments/Updates
Table 64. Hanmi Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Catalent Biologics Basic Information, Area Served and Competitors
Table 66. Catalent Biologics Major Business
Table 67. Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 68. Catalent Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Catalent Biologics Recent Developments/Updates
Table 70. Catalent Biologics Competitive Strengths & Weaknesses
Table 71. FUJIFILM Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. FUJIFILM Pharmaceuticals Major Business
Table 73. FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 74. FUJIFILM Pharmaceuticals Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. FUJIFILM Pharmaceuticals Recent Developments/Updates
Table 76. FUJIFILM Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. CordenPharma Basic Information, Area Served and Competitors
Table 78. CordenPharma Major Business
Table 79. CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 80. CordenPharma Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. CordenPharma Recent Developments/Updates
Table 82. CordenPharma Competitive Strengths & Weaknesses
Table 83. ST Pharm Basic Information, Area Served and Competitors
Table 84. ST Pharm Major Business
Table 85. ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 86. ST Pharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ST Pharm Recent Developments/Updates
Table 88. ST Pharm Competitive Strengths & Weaknesses
Table 89. eTheRNA Basic Information, Area Served and Competitors
Table 90. eTheRNA Major Business
Table 91. eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 92. eTheRNA Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. eTheRNA Recent Developments/Updates
Table 94. eTheRNA Competitive Strengths & Weaknesses
Table 95. Esco Aster Basic Information, Area Served and Competitors
Table 96. Esco Aster Major Business
Table 97. Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 98. Esco Aster Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Esco Aster Recent Developments/Updates
Table 100. Esco Aster Competitive Strengths & Weaknesses
Table 101. Recipharm Basic Information, Area Served and Competitors
Table 102. Recipharm Major Business
Table 103. Recipharm Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 104. Recipharm Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Recipharm Recent Developments/Updates
Table 106. Recipharm Competitive Strengths & Weaknesses
Table 107. Yuantai Biological Technology Basic Information, Area Served and Competitors
Table 108. Yuantai Biological Technology Major Business
Table 109. Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 110. Yuantai Biological Technology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Yuantai Biological Technology Recent Developments/Updates
Table 112. Yuantai Biological Technology Competitive Strengths & Weaknesses
Table 113. GenScript Biotechnology Basic Information, Area Served and Competitors
Table 114. GenScript Biotechnology Major Business
Table 115. GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 116. GenScript Biotechnology Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GenScript Biotechnology Recent Developments/Updates
Table 118. WuXi Biologics Basic Information, Area Served and Competitors
Table 119. WuXi Biologics Major Business
Table 120. WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Product and Services
Table 121. WuXi Biologics Lipid Nanoparticles (LNPs) CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Lipid Nanoparticles (LNPs) CDMO Service Upstream (Raw Materials)
Table 123. Lipid Nanoparticles (LNPs) CDMO Service Typical Customers
LIST OF FIGURE
Figure 1. Lipid Nanoparticles (LNPs) CDMO Service Picture
Figure 2. World Lipid Nanoparticles (LNPs) CDMO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Lipid Nanoparticles (LNPs) CDMO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Lipid Nanoparticles (LNPs) CDMO Service Revenue (2018-2029) & (USD Million)
Figure 13. Lipid Nanoparticles (LNPs) CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Lipid Nanoparticles (LNPs) CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Lipid Nanoparticles (LNPs) CDMO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lipid Nanoparticles (LNPs) CDMO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lipid Nanoparticles (LNPs) CDMO Service Markets in 2022
Figure 27. United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Lipid Nanoparticles (LNPs) CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type in 2022
Figure 31. mRNA-LNP CDMO
Figure 32. siRNA-LNP CDMO
Figure 33. pDNA-LNP CDMO
Figure 34. Others
Figure 35. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Type (2018-2029)
Figure 36. World Lipid Nanoparticles (LNPs) CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Lipid Nanoparticles (LNPs) CDMO Service Market Size Market Share by Application in 2022
Figure 38. Vaccines and Drugs
Figure 39. Diagnostics and Medical Imaging
Figure 40. Nanotherapeutics
Figure 41. Others
Figure 42. Lipid Nanoparticles (LNPs) CDMO Service Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
